Morgan Stanley »

Monopar Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $284k 7.9k 35.78
2024-12-31 $84k 3.8k 22.00

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Morgan Stanley

Top funds holding Monopar Therapeutics

Henderson Group
Adage Capital Partners GP
RA Capital Management
Wellington Management Company
Vanguard Group
BlackRock
Deerfield Management Company
Saturn V Capital Management
TCG Crossover Management
ADAR1 Capital Management
Vivo Capital
Geode Capital Management
Affinity Asset Advisors
State Street Corporation
Driehaus Capital Management

View all funds holding Monopar Therapeutics